Condition
Cervical Cancer Stage IB2
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Withdrawn1
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04770090Not ApplicableActive Not Recruiting
Research of Circulating Tumor Cells Released During Cervical Cancer Surgery
NCT06836869Not ApplicableRecruitingPrimary
Modified Tumor-free Techniques Operation to Cervical Cancer
NCT07256977Not ApplicableNot Yet RecruitingPrimary
Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer
NCT07248878RecruitingPrimary
Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy
NCT03146039Phase 2Withdrawn
Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB
Showing all 5 trials